Baxter International (BAX) PT Raised to $95 at BMO Capital
Tweet
Share
E-mail
Get Alerts BAX Hot Sheet
Price: $19.66 -1.16%
Rating Summary:
12 Buy, 14 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
12 Buy, 14 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
BMO Capital analyst Joanne Wuensch raised the price target on Baxter International (NYSE: BAX) to $95.00 (from $88.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
- Incyte (INCY) PT Raised to $105 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
